Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REALITY: Transfusion Strategies in AMI
NCT02648113Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2016
- Primary completion
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 2
01
Overview
Randomised, open-label trial of red blood cells in anemia (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Cost-effectiveness ratio at 30 days. Started Mar 2016; status: completed.
02
Drugs
red blood cells
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02648113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02648113.